<em>Dealmaker’s Diary</em>: Shining a Light on a High-Wattage Dividend Payer

Dealmaker’s Diary: Shining a Light on a High-Wattage Dividend Payer

Alpesh is flipping the script with this dividend-paying utility that’s concentrated in the Pacific Northwest…


Pharmacist recommends medicines to customers. Asking the questions of medication. Professional Asian male pharmacist giving prescription medications to female patient customers at drugstore shelves.

Buy This, Not That: A Big Dose of 5 Big Pharma Stocks

Which of these five drugmakers stocks hands out a prescription for portfolio health?


<em>Monday Takeaways</em>: A Perfect Storm of Politics, Earnings, and Economic Data

Monday Takeaways: A Perfect Storm of Politics, Earnings, and Economic Data

Tech stocks took a beating last week… the markets jumped in early Monday trading… and some big data awaits. Here’s what’s affecting your money this week…


<em>Dealmaker’s Diary</em>: Get Paid to Play the Stock Market

Dealmaker’s Diary: Get Paid to Play the Stock Market

This dividend-paying asset manager is ready for a breakout to its former all-time high.


<em>Buy This, Not That</em>: Are the Big Banks Big Buys?

Buy This, Not That: Are the Big Banks Big Buys?

While the big banks are touting impressive headline numbers, with record highs and substantial profit increases, there’s something lurking under the surface…


<em>Monday Takeaways</em>: Bank on Trouble Coming

Monday Takeaways: Bank on Trouble Coming

Forget the back-to-back-to-back market highs. The latest bank earnings reports are a warning…


<em>Dealmaker’s Diary</em>: Add This Undervalued Retail Pioneer to Your Cart

Dealmaker’s Diary: Add This Undervalued Retail Pioneer to Your Cart

This bulk retail pioneer has been serving up jumbo-sized gains over the past few years. Get the ticker here.


<em>Buy This, Not That</em>: Put These Controversial Stocks on Your “Buy” List

Buy This, Not That: Put These Controversial Stocks on Your “Buy” List

It doesn’t matter what they do or where they do it. Are they making money? These five Chinese stocks are.


<em>Monday Takeaways</em>: The Magnificent Seven’s Creative Destruction

Monday Takeaways: The Magnificent Seven’s Creative Destruction

Barron’s is out with a piece that suggests it’s time to get out of the Magnificent Seven. Here’s why that’s wrong.


<em>Buy This, Not That</em>: Summer Sizzlers and Vacation Busts

Buy This, Not That: Summer Sizzlers and Vacation Busts

As summer travel kicks into high gear, here are six travel and leisure stocks that should be either added to your bucket list… or be given one-star reviews.


BROUGHT TO YOU BY MANWARD PRESS